Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Aug 27 2020
Published Aug 27 2020
4 min read

Press Release Aug 27 2020

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 27, 2020, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.".

View Attachment